Home
Resources
Publications
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review

Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review

Jia-Jun Li, Yan-Yan Yan, Hong-Mei Sun, Yun Liu, Chao-Yue Su, Hu-Biao Chen, Jian-Ye Zhang

Front Pharmacol. 2019 Jul 12;10:746.

PMID: 31354475

Abstract:

As a quinonemethide triterpenoid extracted from species of the Celastraceae and Hippocrateaceae, pristimerin has been shown potent anti-cancer effects. Specifically, it was found that pristimerin can affect many tumor-related processes, such as apoptosis, autophagy, migration and invasion, vasculogenesis, and drug resistance. Various molecular targets or signaling pathways are also involved, such as cyclins, reactive oxygen species (ROS), microRNA, nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and PI3K/AKT/mammalian target of rapamycin (mTOR) pathways. In this review, we will focus on the research about pristimerin-induced anti-cancer activities to achieve a deeper understanding of the targets and mechanisms, which offer evidences suggesting that pristimerin can be a potent anti-cancer drug.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP1258840	Pristimerin		1258-84-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: